tiprankstipranks
Acrivon Therapeutics, Inc. (ACRV)
NASDAQ:ACRV
US Market
ACRV
Acrivon Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see ACRV full AI Analyst Report?

Acrivon Therapeutics, Inc. (ACRV) Financial Statements

840 Followers

Acrivon Therapeutics, Inc. Financial Overview

Acrivon Therapeutics, Inc.'s market cap is currently $74.00M. The company's EPS TTM is $-0.49; its P/E ratio is -1.19; Acrivon Therapeutics, Inc. is scheduled to report earnings on March 19, 2026, and the estimated EPS forecast is $-0.53. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -1.36M$ -1.01M$ -536.00K$ 0.00$ 0.00
Operating Income$ -84.11M$ -89.20M$ -67.24M$ -32.66M$ -16.18M
EBITDA$ -82.76M$ -79.55M$ -59.85M$ -32.29M$ -16.15M
Net Income$ -77.91M$ -80.56M$ -60.39M$ -31.17M$ -16.24M
Balance Sheet
Cash & Short-Term Investments$ 118.58M$ 179.48M$ 127.46M$ 127.75M$ 99.60M
Total Assets$ 129.72M$ 196.59M$ 138.26M$ 181.23M$ 106.59M
Total Debt$ 2.71M$ 3.65M$ 4.64M$ 4.96M$ 5.63M
Net Debt$ -38.79M$ -36.17M$ -31.37M$ -24.56M$ -93.97M
Total Liabilities$ 17.20M$ 19.80M$ 17.07M$ 10.75M$ 130.40M
Stockholders' Equity$ 112.52M$ 176.79M$ 121.19M$ 170.47M$ -23.81M
Cash Flow
Free Cash Flow$ -65.33M$ -68.44M$ -43.93M$ -32.28M$ -14.22M
Operating Cash Flow$ -63.66M$ -65.67M$ -42.64M$ -30.12M$ -13.98M
Investing Cash Flow$ 66.10M$ -51.77M$ 50.72M$ -141.68M$ -238.00K
Financing Cash Flow$ -749.00K$ 121.03M$ -1.55M$ 101.71M$ 112.22M
Currency in USD

Acrivon Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Acrivon Therapeutics, Inc. Debt to Assets

Balance Sheet >

Acrivon Therapeutics, Inc. Cash Flow

Cash Flow >

Acrivon Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >